Salem Investment Counselors’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-1,002
| Closed | -$54.8K | – | 634 |
|
|
2025
Q3 | $54.8K | Hold |
1,002
| – | – | ﹤0.01% | 589 |
|
|
2025
Q2 | $53.2K | Hold |
1,002
| – | – | ﹤0.01% | 575 |
|
|
2025
Q1 | $43.4K | Hold |
1,002
| – | – | ﹤0.01% | 597 |
|
|
2024
Q4 | $56.3K | Hold |
1,002
| – | – | ﹤0.01% | 559 |
|
|
2024
Q3 | $68.3K | Hold |
1,002
| – | – | ﹤0.01% | 516 |
|
|
2024
Q2 | $42.3K | Hold |
1,002
| – | – | ﹤0.01% | 596 |
|
|
2024
Q1 | $69.2K | Hold |
1,002
| – | – | ﹤0.01% | 496 |
|
|
2023
Q4 | $74.1K | Hold |
1,002
| – | – | ﹤0.01% | 486 |
|
|
2023
Q3 | $68.4K | Hold |
1,002
| – | – | ﹤0.01% | 478 |
|
|
2023
Q2 | $94.1K | Hold |
1,002
| – | – | ﹤0.01% | 427 |
|
|
2023
Q1 | $67.9K | Hold |
1,002
| – | – | ﹤0.01% | 480 |
|
|
2022
Q4 | $49.6K | Hold |
1,002
| – | – | ﹤0.01% | 515 |
|
|
2022
Q3 | $33K | Hold |
1,002
| – | – | ﹤0.01% | 545 |
|
|
2022
Q2 | $39K | Hold |
1,002
| – | – | ﹤0.01% | 544 |
|
|
2022
Q1 | $70K | Hold |
1,002
| – | – | ﹤0.01% | 459 |
|
|
2021
Q4 | $78K | Hold |
1,002
| – | – | ﹤0.01% | 487 |
|
|
2021
Q3 | $96K | Hold |
1,002
| – | – | 0.01% | 419 |
|
|
2021
Q2 | $125K | Hold |
1,002
| – | – | 0.01% | 379 |
|
|
2021
Q1 | $132K | Hold |
1,002
| – | – | 0.01% | 339 |
|
|
2020
Q4 | $133K | Hold |
1,002
| – | – | 0.01% | 319 |
|
|
2020
Q3 | $102K | Hold |
1,002
| – | – | 0.01% | 301 |
|
|
2020
Q2 | $87K | Hold |
1,002
| – | – | 0.01% | 312 |
|
|
2020
Q1 | $58K | Hold |
1,002
| – | – | 0.01% | 330 |
|
|
2019
Q4 | $93K | Buy |
1,002
+2
| +0.2% | +$176 | 0.01% | 318 |
|
|
2019
Q3 | $90K | Hold |
1,000
| – | – | 0.01% | 315 |
|
|
2019
Q2 | $118K | Hold |
1,000
| – | – | 0.01% | 282 |
|
|
2019
Q1 | $79K | Buy |
+1,000
| New | +$85.1K | 0.01% | 256 |
|
|
2018
Q4 | – | Sell |
-1,000
| Closed | -$79K | – | 245 |
|
|
2018
Q3 | $79K | Hold |
1,000
| – | – | 0.01% | 256 |
|
|
2018
Q2 | $60K | Hold |
1,000
| – | – | 0.01% | 274 |
|
|
2018
Q1 | $39K | Sell |
1,000
-5,480
| -85% | -$267K | ﹤0.01% | 318 |
|
|
2017
Q4 | $340K | Buy |
6,480
+5,480
| +548% | +$293K | 0.04% | 178 |
|
|
2017
Q3 | $47K | Hold |
1,000
| – | – | 0.01% | 311 |
|
|
2017
Q2 | $35K | Hold |
1,000
| – | – | ﹤0.01% | 350 |
|
|
2017
Q1 | $23K | Hold |
1,000
| – | – | ﹤0.01% | 456 |
|
|
2016
Q4 | $13K | Buy |
+1,000
| New | +$16.1K | ﹤0.01% | 477 |
|
Other funds holding EXAS
HI
PCM
FCM
DKCM
Salem Investment Counselors's EXAS Position: Q4 2025 in Review
Salem Investment Counselors sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 1,002 shares — an estimated $54.8K sold.
Salem Investment Counselors first reported a position in EXAS in Q4 2016 and held it in 35 quarters. The position peaked at $340K in Q4 2017. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.
- Salem Investment Counselors reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
- Salem Investment Counselors sold 1,002 Exact Sciences shares in Q4 2025, an estimated $54.8K.
- Salem Investment Counselors first reported a position in Exact Sciences in Q4 2016 and held it in 35 quarters.
- Salem Investment Counselors's Exact Sciences position peaked at $340K in Q4 2017.
- 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.
Based on Salem Investment Counselors's 13F filing for Q4 2025, filed 12 Jan 2026.